EFEarnings Feed

C

Company dossier

CTI BIOPHARMA CORP

CIK 0000891293SIC 2834Pharmaceutical Preparations

Add to watchlist

Exchange

—

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

SEC profile ↗

Recent filings

Latest submissions

6 items

10-QAccepted Nov 14, 7:00 PM ETAcc 0001032210-99-001627
CELL THERAPEUTICS INC129.1 KB
CELL THERAPEUTICS INC 10-Q
View filing
10-QAccepted Aug 15, 8:00 PM ETAcc 0001032210-99-001249
CELL THERAPEUTICS INC58.5 KB
CELL THERAPEUTICS INC 10-Q
View filing
10-QAccepted May 16, 8:00 PM ETAcc 0000929624-99-000955
CELL THERAPEUTICS INC54.6 KB
CELL THERAPEUTICS INC 10-Q
View filing
10-KAccepted Mar 30, 7:00 PM ETAcc 0000929624-99-000601
CELL THERAPEUTICS INC465.0 KB
CELL THERAPEUTICS INC 10-K
View filing
10-QAccepted Nov 15, 7:00 PM ETAcc 0000929624-98-001876
CELL THERAPEUTICS INC82.3 KB
CELL THERAPEUTICS INC 10-Q
View filing
8-KAccepted Jul 23, 8:00 PM ETAcc 0000929624-98-001284
CELL THERAPEUTICS INC10.4 KB
CELL THERAPEUTICS INC 8-K
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 0

Ticker roster

No tickers on record.

Addresses

business
3101 WESTERN AVENUE SUITE 800
SEATTLE, WA, 98121
mailing
3101 WESTERN AVENUE SUITE 800
SEATTLE, WA, 98121

Former names

CELL THERAPEUTICS INC
1996-06-28 – 2014-05-29